Ononcoplastic surgery of the breast after neoadjuvant systemic therapy
Authors: Е.М. Bit-Sava, А.V. Brosse, М.А. Monogarova, М.G. Kurbanova, А.V. Vlasenko, В.N. Isich, А.Е. Vanin, А.М. Habicheva, V.M. Moiseyenko
DOI: https://www.doi.org/10.31917/2502174
The use of neoadjuvant drug therapy makes it possible to minimize the volume of surgical intervention in patients with breast cancer. De-escalation of surgery, with equivalent rates of relapse-free and overall survival in comparison with radical mastectomy, allows to reduce the frequency of postoperative complications, aesthetic results of surgery and improve the quality of life. The aim of the work is to present up-to-date data on the results and benefits of organ-preserving, oncoplastic resections in patients with locally advanced breast cancer after neoadjuvant chemotherapy.